SCHEMBL17295407

SCHEMBL17295407

Cc1ccc(N=C2SC(=Cc3ccc4c(c3)OCCO4)C(=O)N2CC(C)C)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA9 Q16790 5/20 0.52
▸ CFTR P13569 1/20 0.51
▸ ALDH1A1 P00352 6/20 0.51
▸ MAPT P10636 3/20 0.51
▸ NPSR1 Q6W5P4 3/20 0.51
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ KMT2A Q03164 3/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ POLB P06746 1/20 0.49
▸ GSK3B P49841 1/20 0.43
▸ MITF O75030 1/20 0.43
▸ FAAH O00519 2/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ HTT P42858 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ AURKA O14965 1/20 0.41
▸ MGAM O43451 2/20 0.40
▸ CA12 O43570 2/20 0.40
▸ CA1 P00915 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17295404 1.00 CA9 (0.52) CA9CFTRALDH1A1MAPTNPSR1
SCHEMBL19096574 0.92 CA9 (0.51) CA9CFTRALDH1A1MAPTNPSR1
SCHEMBL19096226 0.91 CA9 (0.62) CA9CFTRALDH1A1MAPTNPSR1
SCHEMBL17302215 0.84 CFTR (0.51) CA9CFTRALDH1A1MAPTNPSR1
SCHEMBL17295281 0.82 FAAH (0.62) CA9CFTRALDH1A1MAPTNPSR1
SCHEMBL17295279 0.82 FAAH (0.62) CA9CFTRALDH1A1MAPTNPSR1
SCHEMBL19096243 0.80 FAAH (0.56) CA9CFTRALDH1A1MAPTKMT2A
SCHEMBL17295538 0.80 FAAH (0.57) CA9ALDH1A1MAPTNPSR1CYP2C9
SCHEMBL17295539 0.80 FAAH (0.57) CA9ALDH1A1MAPTNPSR1CYP2C9
SCHEMBL19096626 0.79 CFTR (0.53) CA9CFTRALDH1A1MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148990-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2017-04-05 — — EP disclosed
WO-2015181337-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback